ALS - AMYOTROPHIC LATERAL SCLEROSIS
Clinical trials for ALS - AMYOTROPHIC LATERAL SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ALS - AMYOTROPHIC LATERAL SCLEROSIS trials appear
Sign up with your email to follow new studies for ALS - AMYOTROPHIC LATERAL SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an iron scavenger slow ALS? small trial tests deferiprone
Disease control CompletedThis study tested a drug called deferiprone in 23 people with ALS. The drug is designed to remove extra iron from the brain, which may help slow the loss of nerve cells. The goal was to see if the drug is safe and if it can slow the worsening of symptoms over time.
Matched conditions: ALS - AMYOTROPHIC LATERAL SCLEROSIS
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated May 26, 2026 06:53 UTC
-
ALS biomarker study seeks clues in blood and spinal fluid
Knowledge-focused CompletedThis study looked at 60 people—ALS patients and healthy volunteers—to measure specific immune and nerve damage markers in their blood and spinal fluid. The goal was to better understand how the immune system's interferon-alpha pathway relates to ALS. Results may help identify pat…
Matched conditions: ALS - AMYOTROPHIC LATERAL SCLEROSIS
Sponsor: Ulysses Neuroscience LTD • Aim: Knowledge-focused
Last updated May 26, 2026 06:53 UTC